Cardiovascular Divisions Boost Medtronic's FYQ2 Top-Line As Hurricane Recovery Continues

Medtronic's revenue of $7.1bn for the second fiscal quarter of 2018 was down 4% year-over-year on an as-reported basis, but up 4% on a comparable constant-currency basis. –It would have been even greater if not for the hurricane that hindered manufacturing operations in Puerto Rico, the company reported Nov 21.

Medtronic-HQ_1200x675
Medtronic Headquarters in Fridley, Minnesota • Source: Medtronic PLC

Medtronic PLC's growth in the second fiscal quarter of 2018 was driven by its cardiovascular divisions – especially transcatheter valves, and would have been even greater if not for the hurricane that hindered manufacturing operations in Puerto Rico.

On Nov 21, the company reported revenue of $7.1bn for the second quarter of fiscal 2018 and earnings per share of $1.07. Revenue was up 3% compared to the second quarter of fiscal 2017 on comparable, constant-currency basis, or 4% excluding the direct impact from Hurricane Maria. That hurricane cost between $55m and $65m, mostly in the company's Minimally Invasive and Restorative Therapies groups

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Cardiology

More from Device Area

Beyond The Bladder: Incontinence Impacts Mental Health

 

In recognition of Mental Health Awareness month, Sarah Jenkins, executive director at the National Association for Continence, discussed the mental health issues that often come with incontinence.

Peerbridge Bets On At-Home Heart Monitoring With Rechargeable, Longer-Lasting ECG Patch

 
• By 

Peerbridge Health is preparing to submit its next-generation ECG patch, CorMDx, for US FDA clearance this quarter, with plans to launch in the second half of 2025. The rechargeable device is designed for continuous, real-time heart monitoring from the hospital to home, aiming to detect early signs of heart failure and reduce emergency room visits.

FDA Announces Classifications On 9 Device Types

 
• By 

The US Food and Drug Administration has announced new classifications for eight device types that reached market via the de novo process, with most of the newly classified products in the diagnostics sector.